Cytotoxicity of a vanadyl(IV) complex with a multidentate oxygen donor in osteoblast cell lines in culture

Medicinal Chemistry

Volumn 6, Issue 1, 2010, Pages 9-23

  Rivadeneira, J ^a   Di Virgilio, A L ^a   Barrio, D A ^a   Muglia, C I ^a   Bruzzone, L ^a   Etcheverry, S B ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Cellular morphology; Chelating ligands; ERK phopsphorylation; GSH GSSG ratio; Mitochondria membrane potential; Osteoblasts; Oxidative stress; Vanadium cytotoxicity

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETIC ACID DERIVATIVE; ACETYLCYSTEINE; ACTIN; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; OXODIACETATE; OXYGEN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VANADYL DERIVATIVE; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TUMOR CELL;

ACTINS; ANIMALS; CELL DEATH; CELL LINE, TUMOR; CYTOSKELETON; CYTOTOXINS; ENZYME ACTIVATION; GLUTATHIONE; GLUTATHIONE DISULFIDE; INTRACELLULAR SPACE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUTRAL RED; ORGANOMETALLIC COMPOUNDS; OSTEOBLASTS; OXYGEN; RATS; REACTIVE OXYGEN SPECIES; VANADIUM;

EID: 77950896402     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340610791208754     Document Type: Article

References (94)

1. Harding, M.M.; Mokdsi, G. Antitumor metallocenes: structure-activity studies and interactions with biomolecules. Curr. Med. Chem., 2000, 7, 1289-1303.
2. Lippard, S.J.; Berg, J. M. Principles of Bioinorganic Chemistry. University Science Books: Mill Valley, CA, 1994.
3. Costas, M.; Mehn, M.P.; Jensen, M.P.; Que L. Jr. Dioxygen activation at mononuclear nonheme iron active sites: enzymes, models, and intermediates. Chem. Rev., 2004, 104, 939-986.
4. Baggio, R.; Perec, M.; Garland, M.T. Polymeric hexaaquahexakis(mu3-2, 2′-oxydiacetato)trizinc(II)digadolinium(III) dodecahydrate. Acta Crystallogr. C, 2003, 59, 175-177.
5. Chao, J.; Xiang, Z.; Zhao-Peng, Y.; Zhi-Yong, W. Molecular chains: two new isomorphous coordination polymers of oxydiacetate. Inorg. Chem. Comm., 2003, 6, 706-709.
6. Nielsen, F.H. Vanadium in mammalian physiology and nutrition. In Sigel, H.; Sigel, A.; Eds. Biological systems, Metal Ions in Biological Systems. New York: Marcel Dekker, 1995, 31, 543-574.
7. Baran, E. Some contributions to the bioinorganic chemistry of vanadium. Anal. Acad. Nac. Cs. Fis. Nat. Buenos Aires, 1996, 46, 35-43.
8. Upreti, R.K. Membrane-vanadium interaction: a toxicokinetic evaluation. Mol. Cell Biochem., 1995, 153, 167-171.
9. Morinville, A.; Maysinger, D.; Shaver, A. From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling. Trends Pharmacol. Sci., 1998, 19, 452-460. (Pubitemid 28545016)
10. Thompson, K.H.; McNeill, J.H.; Orvig, C. Vanadium compounds as insulin mimics. Chem. Rev., 1999, 99, 2561-2572.
11. Djordjevic, C. Antitumor activity of vanadium compounds. Met. Ions. Biol. Syst., 1995, 31, 595-616.
12. Evangelou, A.M. Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol., 2002, 42, 249-265.
13. Hasenknopf, B. Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications. Front. Biosci., 2005, 10, 275-287
14. Cortizo, A.M.; Molinuevo, M.S.; Barrio, D.A.; Bruzzone, L. Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action. Int. J. Biochem. Cell Biol., 2006, 38, 1171-1180.
15. Barrio, D.A.; Cattáneo, E.R.; Apezteguía, M.C.; Etcheverry, S.B. Vanadyl(IV) complexes with saccharides. Bioactivity in osteoblast-like cells in culture. Can. J. Physiol. Pharmacol., 2006, 84, 765-775. (Pubitemid 44897897)
16. Etcheverry, S.B.; Barrio, D.A. In: Vanadium: the Versatile Metal, Ch. 15. Kustin, K.; Pessoa, J.; Crans, D.C. EdS., American Chemical Society: Washington DC, 2007, pp. 204-216.
17. Molinuevo, M.S.; Barrio, D.A.; Cortizo, A.M.; Etcheverry, S.B. Antitumoral properties of two new vanadyl(IV) complexes in osteoblasts in culture: role of apoptosis and oxidative stress. Can. Chem.Pharmacol., 2004, 53,163-172.
18. Molinuevo, M.S.; Cortizo, A.M.; Etcheverry, S.B. Vanadium(IV) complexes inhibit adhesion, migration and colony formation of UMR106 osteosarcoma cells. Can. Chem. Pharmacol., 2008, 61, 767-773.
19. Etcheverry, S.B.; Ferrer, E.G.; Naso, L.; Rivadeneira, J.; Salinas, V.; Williams, P.A.M. Antioxidant effects of the VO(IV) hesperidin complex and its role in cancer chemoprevention. J. Biol. Inorg. Chem., 2008, 13, 435-447.
20. Rivadeneira, J.; Barrio, D.A.; Arrambide, G.; Gambino, D.; Bruzzone, L.; Etcheverry, S.B. Biological effects of a complex of vanadium(V) with salicylaldehyde semicarbazone in osteoblasts in culture: mechanism of action. J. Inorg. Biochem., 2009, 103, 633-642.
21. Gresser, M.; Tracey, A.S. In: Chasteen, N.D.; Ed., Vanadium in Biological Systems, Kluwer Academic Press: Dordrecht 1990, pp. 63-79.
22. Pandey, S.K.; Theberge, J.F.; Bernier, M.; Srivastava, A.K. Phosphatidylinositol 3-kinase requirement in activation of the ras/c-rafl/MEK/ERK and p70 (s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate. Biochemistry, 1999, 38, 14667-14675. (Pubitemid 129517609)
23. Rumora, L.; Hadzija, M.; Maysinger, D.; Zanić-Grubisić, T. Positive regulation of ERK activation and MKP-1 expression by peroxovanadium complex bpV (phen). Cell Biol. Toxicol., 2004, 20, 293-301. (Pubitemid 40575636)
24. Théberge, J.F.; Mehdi, M.Z.; Pandey, S.K.; Srivastava, A.K. Prolongation of insulin-induced activation of mitogen-activated protein kinases ERK 1/2 and phosphatidylinositol 3-kinase by vanadyl sulfate, a protein tyrosine phosphatase inhibitor. Arch. Biochem. Biophys., 2003, 420, 9-17. (Pubitemid 37393369)
25. Cortizo, A.M.; Kreda, S.M. In: Centeno, J.A.; Collery, P.H.; Vernet, G.; Finkelman, R.B.; Gibb, H.; Etienne, J.C.; Eds., Metal Ions in Biology and Medicine Jhon Libbey, Eurotext, Paris 2000, vol. 6, pp. 714-716.
26. Ye, J.; Ding, M.; Zhang, X.; Rojanasakul, Y.; Nedospasov, S.; Vallyathan, V.; Castranova, V.; Shi, X. Induction of TNF alpha in macrophages by vanadate is dependent on activation of transcription factor N-F-kappa B and free radical reactions. Mol. Cell. Biochem., 1999, 198, 193-200. (Pubitemid 29414540)
27. Narla, R.K.; Dong, Y.; Klis, D.; Uckun, F.M. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]). Clin. Cancer Res., 2001, 7, 1094-1110.
28. Valko, M.; Rhodes, C.J.; Moncol, J.; Izakovic, M.; Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol.Interact., 2006, 160, 1-40. (Pubitemid 43227479)
29. Reed, D. J.; Fariss, M. W. Glutathione depletion and susceptibility. Pharmacol. Rev., 1984, 36, 25-33.
30. Mohamadin, A.M.; Hammad, L.A.; El-Bab, M.; Abdel Gawad, H.S. Attenuation of oxidative stress in plasma and tissues of rats with experimentally induced hyperthyroidism by caffeic Acid phenylethyl ester. Basic Clin. Pharmacol. Toxicol., 1996, 100, 84-90.
31. Chen, F.; Vallyathan, V.; Castranova, V.; Shi, X. Cell apoptosis induced by carcinogenic metals. Mol. Cell. Biochem., 2001, 222, 183-188. (Pubitemid 32910334)
32. Sakurai, H. Vanadium distribution in rats and DNA cleavage by vanadyl complex: Implication for vanadium toxicity and biological effects Environ. Health Perspect., 1994, 3, 35-36. (Pubitemid 24316355)
33. Ivancsits, S.; Pilger, A.; Diem, E.; Schaffer, A.; Rüdiger, H. Vanadate induces DNA strand breaks in cultured human fibroblasts at doses relevant to occupational exposure. Mutat. Res., 2002, 519, 25-35. (Pubitemid 34874984)
34. Jelikić-Stankov, M.; Uskoković-Marković, S.; Holclajtner-Antunović, I.; Todorović, M.; Djurdjević, P. Compounds of Mo, V and W in biochemistry and their biomedical activity. J. Trace Elem. Med. Biol., 2007, 21, 8-16. (Pubitemid 46298676)
35. Domingo, J.L. Vanadium: A review of the reproductive and developmental toxicity. Reprod. Toxicol., 1996, 10, 175-182.
36. Sabbioni, E.; Pozzi, G.; Devos, S.; Pintar, A.; Casella, L.; Fischbach, M. The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV)). Carcinogenesis, 1993, 14, 2565-2568. (Pubitemid 24016597)
37. Kordowiak, A.M.; Klein, A.; Goc, A.; Dabroś, W. Comparison of the effect of VOSO4, Na3VO4 and NaVO3 on proliferation, viability and morphology of H35-19 rat hepatoma cell line. Pol. J. Pathol., 2007, 58, 51-57.
38. Altamirano-Lozano, M. Genotoxic effects of vanadium compounds. Invest. Clin., 1998, 39, 39-47.
39. Del Río, D.; Galindo, A.; Vicente, R.; Carlo, M.; Ienco, A.; Masi, D. Synthesis, molecular structure and properties of oxo-vanadium (IV) complexes containing the oxydiacetate ligand. Dalton Trans., 2003, 9, 1813-1820. (Pubitemid 41282376)
40. Rivadeneira, J.; Barrio, D.A.; Etcheverry, S.B.; Baran, E.J. Spectroscopic characterization of a VO2+ complex of oxodiacetic acid and its bioactivity on osteoblast-like cells in culture. Biol. Trace Elem. Res., 2007, 118, 159-166.
41. Del Río, D.; Galindo, A.; Tejedo, J.; Bedoya, F.J.; Ienco, A.; Mealli, C. Synthesis, antiapoptotic biological activity and structure of an oxo-vanadium(IV) complex with an OOO ligand donor set. Inorg. Chem. Commun., 2000, 3, 32-34.
42. 2 in cultured endothelial cells. Arch. Biochem. Biophys., 1993, 302, 348-355.
43. 2 generation. Cell Biol. Toxicol., 2007, 23, 413-420.
44. Qin, Y.; Lu, M.; Gong, X. Dihydrorhodamine 123 is superior to 2,7-dichlorodihydrofluorescein diacetate and dihydrorhodamine 6G in detecting intracellular hydrogen peroxide in tumor cells. Cell Biol. Int., 2008, 32, 224-228. (Pubitemid 351282500)
45. Cortizo, A.M.; Bruzzone, L.; Molinuevo, M.S.; Etcheverry, S.B. A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines. Toxicology, 2000, 147, 89-99.
46. Barrio, D.A.; Williams, P.A.M.; Cortizo, A.M.; Etcheverry, S.B. Synthesis of a new vanadyl(IV) complex with trehalose (TreVO): insulin-mimetic activities in osteoblast-like cells in culture. J Biol. Inorg. Chem., 2003, 8, 459-468.
47. Schedle, A.; Samorapoompichit, P.; Rausch-Fan, X.H.; Franz, A.; Füreder, W.; Sperr, W.R.; Sperr, W.; Ellinger, A.; Slavicek, R.; Boltz-Nitulescu, G.; Valent, P. Response of L-929 fibroblasts, human gingival fibroblasts, and human tissue mast cells to various metal cations. J. Dent. Res., 1995, 74, 1513-1520
48. Harding, C.J.; Henderson, R.K.; Powell, A.K. A new type of hexanuclear iron(III) hydroxo(oxo) cluster. Angewandte Chemie. International edition in English. Angew. Chem., Int. Ed. Engl., 1993, 32, 570-572.
49. Cortizo, A.M.; Etcheverry, S.B. Vanadium derivatives act as growth factor - mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol. Cell Biochem., 1995, 145, 97-102.
50. Sálice, V.C.; Cortizo, A.M.; Gomez Dumm, C.L.; Etcheverry, S.B. Tyrosine phosphorylation and morphological transformation induced by four vanadium compounds on MC3T3E1 cells. Mol. Cell. Biochem., 1999, 198, 119-128. (Pubitemid 29414530)
51. Borenfreund, E.; Puerner, J.A. A simple quantitative procedure using monolayer culture for toxicity assays. J. Tissue Cult. Methods, 1984, 9, 7-9.
52. Holko, P.; Ligeza, J.; Kisielewska, J.; Kordowiak, A.M.; Klein A. The effect of vanadyl sulphate (VOSO4) on autocrine growth of human epithelial cancer cell lines. Pol. J. Pathol., 2008, 59, 3-8. (Pubitemid 351628134)
53. Soares, S.S.; Henao, F.; Aureliano, M.; Gutiérrez-Merino, C. Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization. Chem. Res. Toxicol., 2008, 21, 607-618. (Pubitemid 351498037)
54. Dayeh, V.R.; Schirmer, K.; Bols, N.C. Ammonia-containing industrial effluents, lethal to rainbow trout, induce vacuolisation and Neutral Red uptake in the rainbow trout gill cell line, RTgill-W1. Altern. Lab. Anim., 2009, 37, 77-87.
55. Ohkuma, S.; Poole, B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J.Cell Biol., 1981, 90, 656-664. (Pubitemid 12254921)
56. Olivier, P.; Testard, P.; Marzin, D.; Abbott, D. Effect of high polyol concentrations on the neutral red absorption assay and tetrazolium-MTT test of rat hepatocytes in primary culture. Toxicol. in Vitro, 1995, 9, 133-138.
57. Lefcort, H.; Freedman, Z.; House, S.; Pendleton, M. Hormetic effects of heavy metals in aquatic snails: is a little bit of pollution good? Ecohealth, 2008, 5, 10-17
58. Schmidt, C.M.; Cheng, C.N.; Marino, A.; Konsoula, R.; Barile F.A. Hormesis effect of trace metals on cultured normal and immortal human mammary cells. Toxicol. Ind. Health, 2004, 20, 57-68.
59. Perez-Benito, J.F. Effects of chromium(VI) and vanadium(V) on the lifespan of fish. J.Trace Elem. Med. Biol., 2006, 20, 161-170.
60. Stebbing, A.R. Tolerance and hormesis - increased resistance to copper in hydroids linked to hormesis. Mar. Environ. Res., 2002, 54, 805-809.
61. Etcheverry, S.B.; Crans, D.C.; Keramidas, A.D.; Cortizo, A.M. Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture. Arch Biochem. Biophys., 1997, 338, 7-14.
62. Etcheverry, S.B.; Ferrer, E.G.; Naso, L.; Barrio, D.A.; Lezama, L.; Rojo, T.; Williams, P.A.M. Losartan and its interaction with copper(II): Biological effects. Bioorg. Med. Chem., 2007, 15, 6418-6424.
63. Luber, B.; Candidus, S.; Handschuh, G.; Mentele, E.; Hutzler, P.; Feller, S.; Voss, J.; Höfler, H.; Becker, K.F. Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate. Cell Adhes. Commun., 2000, 7, 391-408. (Pubitemid 30265256)
64. Yang, X.G.; Yang, X.D.; Yuan, L.; Wang, K.; Crans, D.C. The permeability and cytotoxicity of insulin-mimetic vanadium compounds. Pharm. Res., 2004, 21, 1026-1033.
65. Stossel, T.P. From signal to pseudopod. How Cells control cytoplasmic actin assembly. J. Biol. Chem., 1989, 5 18261-18264.
66. Osińska-Królicka, I.; Podsiadly, H.; Bukietyńnska, K.; Zemanek-Zboch, M.; Nowak, D.; Suchoszek-Lukaniuk, K.; Malicka-Blaszkiewicz, M. Vanadium(III) complexes with l-cysteine - stability, speciation and the effect on actin in hepatoma Morris 5123 cells. J. Inorg. Biochem., 2004, 98, 2087-2098.
67. Hacker, G. The morphology of apoptosis. Cell Tissue Res., 2000, 301, 5-17.
68. Yuana, B.; Jefferson, A.M.; Millecchia, L.; Popescu, N.C.; Reynolds, S.H. Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells. Exp. Cell Res., 2007, 313, 3868-3880.
69. Yamazaki, Y.; Tsuruga, M.; Zhou, D.; Fujita, Y.; Shang, X.; Dang, Y.; Kawasaki, K.; Oka, S. Cytoskeletal disruption accelerates caspase-3 activation and alters the intracellular membrane reorganization in DNA damage-induced apoptosis. Exp. Cell Res., 2000, 259, 64-78.
70. Ye, J.; Ding, M.; Leonard, S.S.; Robinson, V.A.; Millecchia, L.; Zhang, X.; Castranova, V.; Vallyathan, V.; Shi, X. Vanadate induces apoptosis in epidermal JB6 P+ cells via hydrogen peroxide-mediated reactions. Mol. Cell Biochem., 1999, 202, 9-17. (Pubitemid 30099733)
71. Zhang, Z.; Huang, C.; Li, J.; Leonard, S.S.; Lanciotti, R.; Butterworth, L.; Shi, X. Vanadate-infuced cell growth regulation and the role of reactive oxygen species. Arch. Biochem. Biophys., 2001, 392, 311-320. (Pubitemid 32757044)
72. Molinuevo, M.S.; Etcheverry, S.B.; Cortizo, A.M. Macrophage activation by a vanadyl-aspirin complex is dependent on L-type calcium channel and the generation of nitric oxide. Toxicology, 2005, 210, 205-212.
73. Jones, D.P., Carlson, J.L.; Mody, V.C.; Cai, J.Y.; Lynn, M.J.; Sternberg, P. Redox state of glutathione in human plasma. Free Rad. Biol. Med., 2000, 28, 625-635.
74. Hwang, C.; Sinskey, A.J.; Lodish, H.F. Oxidized redox state of glutathione in the endoplasmic-reticulum. Science, 1992, 57, 1496-1502.
75. Giovannini, C.; Scazzocchio, B.; Matarrese, P.; Varì, R.; D'Archivio, M.; Di Benedetto, R.; Casciani, S.; Dessì, M.R.; Straface, E.; Malorni, W.; Masella, R. Apoptosis induced by oxidized lipids is associated with up-regulation of p66Shc in intestinal Caco-2 cells: protective effects of phenolic compounds. J Nutr. Biochem., 2008, 19,118-128.
76. Cohen, M.D.; Wei, C.I. Effects of ammonium metavanadate treatment upon macrophage glutathione redox cycle activity, superoxide production, and intracellular glutathione status. J. Leukoc. Biol., 1988, 44,122-129.
77. Herr, I.; Debatin, K.M. Cellular stress response and apoptosis in cancer therapy. Blood, 2001, 98, 2603-2614.
78. Grebenova, D.; Kuzelova, K.; Smetana, K.; Pluskalova, M.; Cajthamlova, H.; Marinov, I.; Fuchs, O.; Soucek, J.; Jarolim, P.; Hrkal, Z. Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells. J. Photochem. Photobiol. B., 2003, 69, 71-85.
79. Mayer, B.; Oberbauer, R. Mitochondrial regulation of apoptosis. News Physiol. Sci., 2003, 18, 89-94.
80. Kim, R.; Tanabe, K.; Uchida, Y.; Emi, M.; Inoue, H.; Toge, T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother. Pharmacol., 2002, 50, 343-352. (Pubitemid 35440522)
81. Darzynkiewicz, Z.; Traganos, F.; Staiano-Coico, L.; Kapuscinski, J.; Melamed, M.R. Interaction of rhodamine 123 with living cells studied by flow cytometry. Cancer Res., 1982, 42, 799-806.
82. Lopez-Mediavilla, C.; Orfao, A.; Garcia, M.V.; Medina, J.M. Changes in adult rat liver mitochondrial populations at different energy states analyzed by flow cytometry. Biochim. Biophys. Acta, 1995, 1232, 27-32.
83. Huang, C.; Zhang, Z.; Ding, M.; Li, J.; Ye, J.; Leonard, S.S.; Shen, H.M.; Butterworth, L.; Lu, Y.; Costa, M.; Rojanasakul, Y.; Castranova, V.; Vallyathan, V.; Shi, X. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J. Biol. Chem., 2000, 275, 32516-32522.
84. D'Cruz, O.J.; Ghosh, P.; Uckun, F.M.; Fatih, M. Spermicidal activity of chelated complexes of bis(cyclopentadienyl)vanadium(IV). Mol. Hum. Reprod., 1998, 4, 683-693. (Pubitemid 28352505)
85. D'Cruz, O.J.; Donga, Y.; Uckun, F.M. Spermicidal activity of oxovanadium(iv) complexes of 1,10-phenanthroline, 2,2′-bipyridyl, 5′-bromo-2′-hydroxyacetophenone and derivatives in humans. Biol.Reprod., 1999, 60, 435-444.
86. Wang, Z.; Bonner, J.C. Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts. Am. J. Respir. Cell. Mol. Biol., 2000, 22, 590-596.
87. Blazquez, C.; Galve-Roperh, I.; Guzmán, M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J., 2000, 14, 2315-2322.
88. Fu, Y.; Wang, Q.; Yang, X-G.; Yang, X-D.; Wang, K. Vanadyl bisacetylacetonate induced G1/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells. J Biol. Inorg. Chem., 2008, 13, 1001-1009.
89. D'Onofrio, F.; Le, M.Q.; Chiasson, J.L.; Srivastava, A.K. Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation. FEBS Lett., 1994, 340, 269-274.
90. Okajima, T.; Nakamura, K.; Zhang, H.; Ling, N.; Tanabe, T.; Yasuda, T.; Rosenfeld, R.G. Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs. Endocrinology, 1992, 130, 2201-2212.
91. Hissin, P.J.; Hilf, R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem., 1976, 74, 214-226.
92. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 249-254.
93. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227, 680-685.
94. Shang, X.J.; Yao, G.; Ge, J.P.; Sun, Y.; Teng, W.H.; Huang, Y.F. Procyanidin induces apoptosis and necrosis of prostate cancer cell line PC-3 in mitochondrion-dependent manner. J. Androl., 2009, 30, 122-126.